- Home
- MIST vs RLAY Comparison
MIST vs RLAY Comparison
Compare MIST & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- RLAY
- Stock Information
- Founded
- MIST 2003
- RLAY 2015
- Country
- MIST Canada
- RLAY United States
- Employees
- MIST N/A
- RLAY N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MIST Health Care
- RLAY Health Care
- Exchange
- MIST Nasdaq
- RLAY Nasdaq
- Market Cap
- MIST 53.9M
- RLAY N/A
- IPO Year
- MIST N/A
- RLAY 2020
- Fundamental
- Price
- MIST $1.24
- RLAY $3.10
- Analyst Decision
- MIST Strong Buy
- RLAY Strong Buy
- Analyst Count
- MIST 2
- RLAY 10
- Target Price
- MIST $9.50
- RLAY $19.33
- AVG Volume (30 Days)
- MIST 2.0M
- RLAY 2.7M
- Earning Date
- MIST 05-12-2025
- RLAY 05-05-2025
- Dividend Yield
- MIST N/A
- RLAY N/A
- EPS Growth
- MIST N/A
- RLAY N/A
- EPS
- MIST N/A
- RLAY N/A
- Revenue
- MIST N/A
- RLAY $10,007,000.00
- Revenue This Year
- MIST N/A
- RLAY N/A
- Revenue Next Year
- MIST N/A
- RLAY $440.45
- P/E Ratio
- MIST N/A
- RLAY N/A
- Revenue Growth
- MIST N/A
- RLAY N/A
- 52 Week Low
- MIST $0.63
- RLAY $1.78
- 52 Week High
- MIST $2.75
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- MIST 53.98
- RLAY 55.96
- Support Level
- MIST $1.09
- RLAY $2.53
- Resistance Level
- MIST $1.37
- RLAY $3.29
- Average True Range (ATR)
- MIST 0.10
- RLAY 0.25
- MACD
- MIST 0.10
- RLAY 0.12
- Stochastic Oscillator
- MIST 89.28
- RLAY 87.37
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).